Big Moving Stock keep track of the biggest moving stocks in the market.


Nasdaq: GOOG NFLX AMZN BIIB IBB TSLA WYNN ALXN SLXP AMGN GMCR COST Z SSYS AAPL GILD WDC SNDK TRIP
Nyse: ACT LNKD V PXD IVV IBM GS AGN SPG TWC FDX MMM CMI APD BA GD TMO CVX WLP URI
New Highs: GS LMT NOC GD RTN PRU CVS VFC LB LLY DPS KSS FL ADM NDAQ WOOF IRF CSX IMS CTLT

The Hot Industries

Aerospace/Defense Products & Services 2
Personal Services 1
Diversified Investments 1

The Hot Sectors

Services 4
Consumer Goods 4
Industrial Goods 3

SPPI Stock Chart


SPPI
Analyze

Sector:

Healthcare
Daily

Industry:

Biotechnology
Weekly

Employees:

N/A
Monthly

Website:

http://www.sppirx.com

SPPI Spectrum Pharmaceuticals, Inc.

Spectrum Pharmaceuticals, Inc., a biotechnology company, develops and commercializes oncology and hematology drug products. The company’s commercialized drug products include FUSILEV for the treatment of patients with metastatic colorectal cancer, rescue after high-dose methotrexate therapy in osteosarcoma, and to diminish the toxicity and counteract the effects of impaired methotrexate elimination and of inadvertent overdosage of folic acid antagonists; FOLOTYN, a folate analogue metabolic inhibitor for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma; ZEVALIN injection for intravenous use as a prescription medication; and MARQIBO, a sphingomyelin/cholesterol liposome-encapsulated formulation of the anticancer drug vincristine for the treatment of adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia. It also develops BELEODAQ for the treatment of various hematological and solid tumors; Captisol-enabled MELPHALAN, an intravenous formulation of MELPHALAN for clinicians and patients in the multiple myeloma transplant setting; APAZIQUONE to treat non-muscle invasive bladder cancer; and SPI-2012 for the treatment of chemotherapy-induced neutropenia. The company sells its drugs through a direct sales force in the United States; and through distributors in Europe and Japan. It has licensing and development agreement with Cell Therapeutics, Inc.; license agreement with Merck & Cie AG and Cydex Pharmaceuticals, Inc.; development and commercialization collaboration agreement with Allergan; collaboration agreement with Nippon Kayaku Co., Ltd.; licensing and collaboration agreement with TopoTarget A/S; and co-development and commercialization agreement with Hanmi Pharmaceutical Company. The company was formerly known as NeoTherapeutics, Inc. and changed its name to Spectrum Pharmaceuticals, Inc. in December 2002. Spectrum Pharmaceuticals, Inc. was founded in 1987 and is headquartered in Henderson, Nevada.

favicon

InPlay from Briefing.com

16 Sep 2014, 10:56 amInPlay from Briefing.com
favicon

Spectrum Pharmaceuticals to Advance Neutropenia Drug - Analyst Blog

10 Sep 2014, 5:19 pmSpectrum Pharmaceuticals to Advance Neutropenia Drug - Analyst Blog
favicon

Spectrum Pharmaceuticals to Advance Neutropenia Drug

10 Sep 2014, 2:20 pmSpectrum Pharmaceuticals (SPPI) announced its intention to initiate a phase III study on SPI-2012 next year.
favicon

Why Spectrum Fell on Beleodaq Approval but Will Rocket on Melphalan Approval

18 Aug 2014, 12:18 pmSpectrum's Beleodaq for Non-Hodgkin's lymphoma received FDA approval on July 3, but the stock then fell 26%. The same thing won't happen with Melphalan because sales numbers are already established. Click to view a price quote on SPPI . Click to research the Drugs industry.